The role of ABCG2 in health and disease: Linking cancer therapy resistance and other disorders

This publication has 135 references indexed in Scilit:

• Synthesis of the Multidrug Reversal Agent Ko143 and Its Parent Natural Product Fumitremorgin C
  Helvetica Chimica Acta, 2023
• Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
  Clinical and Experimental Medicine, 2022
• Interaction of crown ethers with the ABCG2 transporter and their implication for multidrug resistance reversal
  Histochemistry and Cell Biology, 2022
• Multidrug efflux transporter ABCG2: expression and regulation
  Cellular and Molecular Life Sciences, 2021
• What monomeric nucleotide binding domains can teach us about dimeric ABC proteins
  FEBS Letters, 2020
• Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter
  Cellular and Molecular Life Sciences, 2019
• Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis
  Journal of Cellular Physiology, 2017
• Transmembrane Domain Single-Nucleotide Polymorphisms Impair Expression and Transport Activity of ABC Transporter ABCG2
  Pharmaceutical Research, 2017
• ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout
  Annals of Clinical and Translational Neurology, 2015
• Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic
  International Journal of Cancer, 2003